Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data

JAP Da Silva, JWG Jacobs, JR Kirwan, M Boers, K Saag, LBS Inês, EJP de Koning, F Buttgereit, M Cutolo, H Capell, R Rau, JWJ Bijlsma

Research output: Contribution to journalArticle (Academic Journal)peer-review

433 Citations (Scopus)

Abstract

Adverse effects of glucocorticoids have been abundantly reported. Published reports on low dose glucocorticoid treatment show that few of the commonly held beliefs about their incidence, prevalence, and impact are supported by clear scientific evidence. Safety data from recent randomised controlled clinical trials of low dose glucocorticoid treatment in RA suggest that adverse effects associated with this drug are modest, and often not statistically different from those of placebo.
Translated title of the contributionSafety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data
Original languageEnglish
Pages (from-to)285 - 293
Number of pages9
JournalAnnals of the Rheumatic Diseases
Volume65 (3)
DOIs
Publication statusPublished - Mar 2006

Bibliographical note

Publisher: BMJ Group

Fingerprint

Dive into the research topics of 'Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data'. Together they form a unique fingerprint.

Cite this